pyctx.com | ACN 098 391 961 1 12 October 2026 2026 ANNUAL GENERAL MEETING PERTH, Australia and SAN FRANCISCO, California – 12 October 2026 PYC Therapeutics Limited (ASX:PYC) (PYC or the Company) advises that the Annual General Meeting of the Company (AGM) will be held on Thursday, 12 November...
PYC Therapeutics: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 57 pages · English
Summary by 6ix AI
PYC Therapeutics Limited has issued a notice for its upcoming Annual General Meeting, scheduled for November at a specified location in Western Australia. The notice includes details on the agenda, which covers the Annual Report and various resolutions for shareholder voting. Shareholders are encouraged to vote by proxy if they cannot attend in person, with instructions provided in the accompanying documents. The document also outlines voting exclusions and prohibitions related to certain resolutions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Application for quotation of securities - PYC
- Notification of cessation of securities - PYC
- PKD Program - Presentation of Data at ASN Conference
- RP11 program - presentation at Euretina 2026
- PKD - First Patient Dosed in OLE Study
Later from PYC Therapeutics
- Exercise of Options and Cleansing Notice
- PKD Program - ASN Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Change of Director's Interest Notice
- Annual General Meeting - Conference Link
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics